Funding for this research was provided by:
T2 Biosystems (-)
Received: 23 September 2019
Accepted: 23 April 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Rhode Island Hospital IRB and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Dr. Mylonakis has received grant support from T2 Biosystems, Sanofi, Cidara Therapeutics and Kaleido Biosciences. The rest of the authors have disclosed no competing interests.